RGBP
OQB Regen Biopharma, Inc.$0.0002 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0002, and at the day’s high of $0.0002
- YTD change
- -97.30%
- vs 20-day SMA
- +104.39%
- vs 200-day SMA
- -85.33%
Price ranges
Price & Performance
-0.00 (-66.67%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $2.6150
- RGBP is down 97% since the beginning of the year
- RGBP is down 99% over the past 12 months
- RGBP is up 100% over the past 1 month
- 0% of all RGBP investors are betting against RGBP
RGBP reads n/a: price sits above one of the two key moving averages, the 12-month move is -98.8%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- +76.80%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. It also focuses on mRNA and small molecule therapies for treating cancer and autoimmune disorders. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
